Venous thromboembolic events are rare after shoulder surgery: Analysis of a national database

Journal of Shoulder and Elbow Surgery

Volumn 20, Issue 5, 2011, Pages 764-770

  Jameson, Simon S ^a   James, Philip ^b   Howcroft, Daniel W J ^c   Serrano Pedraza, Ignacio ^d   Rangan, Amar ^a   Reed, Mike R ^d   Candal Couto, Jaime ^d  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b CHKS Healthcare Intelligence Services   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Prophylaxis; Shoulder surgery; Venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; DATA BASE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMERUS FRACTURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH SERVICE; OSTEOSYNTHESIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SHOULDER ARTHROPLASTY; SHOULDER ARTHROSCOPY; SHOULDER HEMIARTHROPLASTY; SHOULDER SURGERY; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 79959294521     PISSN: 10582746     EISSN: 15326500     Source Type: Journal    
DOI: 10.1016/j.jse.2010.11.034     Document Type: Article

References (26)

1. American Academy of Orthopaedic Surgeons. Clinical guidelines on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. Adopted by the American Academy of Orthopedic Surgeons Board of Directors May 2007. Available from: Accessed November 18, 2010. http://www.aaos.org/research/guidelines/PE_guideline.pdf.
2. Audit Commission. Information and Data Quality in the NHS. Key messages from three years of independent review. Health Bulletin, March 2004. Available from: Accessed November 18, 2010. http://www.audit-commission.gov.uk/SiteCollectionDocuments/AuditCommissi onReports/NationalStudies/20040330dataquality.pdf.
3. Baroletti S., Piovella C., Fanikos J., Labreche M., Lin J., Goldhaber S.Z. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thromb Haemost 2008, 100:1130-1135. 10.1160/TH08-05-0312.
4. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
5. Dailiana Z.H., Malizos K.N., Vartimidis S., Hantes M., Basdekis G., Rigopoulos N. Low-molecular-weight heparin for prevention of thrombosis: inverted role. J Trauma 2007, 63:E111-E115.
6. Fleiss J.L., Levin B., Paik M.C. Statistical methods for rates and proportions 2003, John Wiley & Sons, New York. 3rd ed.
7. Freedman K.B., Brookenthal K.R., Fitzgerald R.H., Williams S., Lonner J.H. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000, 82:929-938.
8. Friedman R.J., Gallus A.S., Cushner F.D., Fitzgerald G., Anderson F.A. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin 2008, 24:87-97.
9. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133-6(Suppl):381-453.
10. Haas S.B., Barrack R.L., Westrich G., Lachiewicz P.F. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2008, 90-12:2764-2780.
11. Jameson S.S., Bottle A., Malviya A., Muller S.D., Reed M.R. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg Br 2010, 92:123-129. 10.1302/0301-620X.92B1.22751.
12. Kapoor A., Chuang W., Radhakrishnan N., Smith K.J., Berlowitz D., Segal S.B., et al. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics 2010, 28:521-538. 10.2165/11535210-000000000-00000.
13. Lyman S., Sherman S., Carter T.I., Bach P.B., Mandl L.A., Marx R.G. Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res 2006, 448:152-156. 10.1097/01.blo.0000194679.87258.6e.
14. National Institute for Health and Clinical Excellence. Available from:. Accessed Sept 1, 2010. http://www.nice.org.uk.
15. National Institute for Health and Clinical Excellence. CG92 Venous thromboembolism-reducing the risk: full guideline. Available from: January 2010. Accessed May 21, 2010. http://www.nice.org.uk/nicemedia/live/12695/47920/47920.pdf.
16. National Institute for Health and Clinical Excellence. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. Available from: Accessed Sept 1, 2010. http://www.nice.org.uk/Guidance/CG46/.
17. National Joint Registry. 5th annual report. Available from: Accessed April 23, 2009. http://www.njrcentre.org.uk/NjrCentre/LinkClick.aspx?fileticket=Da4%2b2s UVa%2fI%3d%26tabid=86%26mid=523.
18. Nicolaides A.N., Fareed J., Kakkar A.K., et al. Prevention and treatment of venous thromboembolism Inter-national Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006, 25:101-161.
19. Parvizi J., Azzam K., Rothman R.H. Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines. J Arthroplasty 2008, 23(Suppl):2-5. 10.1016/j.arth.2008.06.028.
20. Patel V.P., Walsh M., Sehgal B., Preston C., DeWal H., Di Cesare P.E. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89:33-38. 10.2106/JBJS.F.00163.
21. Pellegrini V.D., Donaldson C.T., Farber D.C., Lehman E.B., Evarts C.M. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res 2006, 452:21-27. 10.1097/01.blo.0000229357.19867.84.
22. Scottish Intercollegiate Guidelines Network (SIGN). Available from: Accessed Sept 1, 2010. http://www.sign.ac.
23. Shortt N.L., Robinson C.M. Mortality after low-energy fractures in patients aged at least 45 years old. J Orthop Trauma 2005, 19:396-400. 10.1097/01.bot.0000155311.04886.7e.
24. Sweetland S., Green J., Liu B., Berrington de González A., Canonico M., Reeves G., et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009, 339. b4583-91. doi:10.1136/bmj.b4583.
25. Westaby S., Archer N., Manning N., Adwani S., Grebenik C., Ormerod O., et al. Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality. BMJ 2007, 335:759. 10.1136/bmj.39318.644549.AE.
26. Willis A.A., Warren R.F., Craig E.V., Adler R.S., Cordasco F.A., Lyman S., et al. Deep vein thrombosis after reconstructive shoulder arthroplasty: a prospective observational study. J Shoulder Elbow Surg 2009, 18:100-106. 10.1016/j.jse.2008.07.011.